Evidence map›Paper›PMID 26991857›Full record

ArticleBritish journal of haematology2017

Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens.

Julio Delgado, Torsten Bielig, Lizette Bonet, Elena Carnero-Montoro, Xose S Puente, Dolors Colomer, Elena Bosch, Elias Campo, Francisco Lozano

Abstract readLetter
In one paragraph

Article in British journal of haematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julio DelgadoDepartment d'Hematologia, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Torsten BieligImmunoreceptors del Sistema Innat i Adaptatiu, IDIBAPS, Barcelona, Spain.
Lizette BonetImmunoreceptors del Sistema Innat i Adaptatiu, IDIBAPS, Barcelona, Spain.
Elena Carnero-MontoroDepartament de Ciències Experimentals i de la Salut, Institut de Biologia Evolutiva (UPF-CSIC), Universitat Pompeu Fabra Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.
Xose S PuenteDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.
Dolors ColomerUnitat de Hematopatologia, Departament d'Anatomia Patològica, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Elena BoschDepartament de Ciències Experimentals i de la Salut, Institut de Biologia Evolutiva (UPF-CSIC), Universitat Pompeu Fabra Parc de Recerca Biomèdica de Barcelona, Barcelona, Spain.
Elias CampoUnitat de Hematopatologia, Departament d'Anatomia Patològica, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Francisco LozanoImmunoreceptors del Sistema Innat i Adaptatiu, IDIBAPS, Barcelona, Spain.

Funding

Worldwide Cancer Research 14-1275
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesAmino Acid SubstitutionPolymorphism, GeneticAntineoplastic Combined Chemotherapy ProtocolsCD5 AntigensGenotypeHumansLeukemia, Lymphocytic, Chronic, B-CellPolymorphism, Single NucleotidePrognosisSurvival AnalysisTreatment OutcomeCD5 AntigensB1a lymphocytesB-cell receptor signallingCD5 polymorphismchronic lymphocytic leukaemiaprogression-free survival

Identifiers

PMID26991857
PMCPMC5381713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.